Tullis Health Investors — 2015 Investments

1 investments dated 2015 · listed companies and verified rows first · show all

Exagenexagen.com in 𝕏NASDAQ: XGNJul 2015

Exagen develops diagnostic and monitoring tests for autoimmune diseases, including tools to distinguish connective tissue disease and assess lupus prognosis and progression.

BiotechDigital HealthHealthtechMedical DevicesVista, US

Thierry Dervieux(Executive Officer)inWendy Swedick(Executive Officer)Fortunato R. Rocca(Executive Officer, Director)John Aballi(President & CEO)in Jeffrey Black(Chief Financial Officer and Corporate Secretary)in

Board seatJames L.L. Tullis· per SEC Form D

Co-investorsCottonwood Technology Fund EPIC VENTURES H.I.G. Capital H.I.G. HealthBridge Partners MESA VERDE VENTURE PARTNERS Sun Mountain Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.